| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 661471 | 70058 | KALPRESS PLUS 320 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KALPRESS PLUS 320 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 320 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70058/70058_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70058/70058_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | LABORATORIOS GEBRO PHARMA S.A. | 2008-09-17 | 1 | 1 | 1 | 2008-09-17 | 2008-09-17 | 0 | 2011-10-06 | View Edit Delete | ||||||||||||
| 661473 | 70060 | KALPRESS PLUS FORTE 320 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KALPRESS PLUS FORTE 320 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 320 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70060/70060_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70060/70060_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | LABORATORIOS GEBRO PHARMA S.A. | 2008-09-17 | 1 | 1 | 1 | 2008-09-17 | 2008-09-17 | 0 | 2011-10-06 | View Edit Delete | ||||||||||||
| 661163 | 69909 | EPTADONE 100 mg SOLUCION ORAL | EPTADONE 100 mg SOLUCION ORAL, 1 frasco unidosis de 20 ml | 100 mg | 6 | 1 | 17 | 1 frasco unidosis de 20 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69909/69909_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69909/69909_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 661167 | 69913 | EPTADONE 20 mg SOLUCION ORAL | EPTADONE 20 mg SOLUCION ORAL, 1 frasco unidosis de 20 ml | 20 mg | 6 | 1 | 17 | 1 frasco unidosis de 20 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69913/69913_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69913/69913_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 661524 | 07413001 | GLIOLAN 30 MG/ML POLVO PARA SOLUCION ORAL | GLIOLAN 30 MG/ML POLVO PARA SOLUCION ORAL, 1 frasco | 1.500 mg | 6 | 50 | 26 | 1 frasco | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07413001/07413001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07413001/07413001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40575 | LABORATORIOS GEBRO PHARMA S.A. | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 0 | 2011-02-15 | View Edit Delete | ||||||||||||
| 662082 | 08484003 | ICANDRA 50 mg/850 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ICANDRA 50 mg/850 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 50 mg/850 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08484003/08484003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08484003/08484003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS GEBRO PHARMA S.A. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2009-01-09 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 662083 | 08484009 | ICANDRA 50 mg/1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ICANDRA 50 mg/1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 50 mg/1.000 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08484009/08484009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08484009/08484009_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS GEBRO PHARMA S.A. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2009-01-09 | 0 | 2011-02-24 | View Edit Delete | ||||||||||||
| 662088 | 08486003 | XILIARX 50 mg COMPRIMIDOS | XILIARX 50 mg COMPRIMIDOS, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08486003/08486003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08486003/08486003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS GEBRO PHARMA S.A. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2009-01-09 | 1 | 2011-02-24 | View Edit Delete | ||||||||||||
| 662089 | 08486005 | XILIARX 50 mg COMPRIMIDOS | XILIARX 50 mg COMPRIMIDOS, 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08486005/08486005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08486005/08486005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS GEBRO PHARMA S.A. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2009-01-09 | 1 | 2011-02-24 | View Edit Delete | ||||||||||||
| 662920 | 70804 | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. , 5 parches | 35 microgramos/h | 74 | 5 | 28 | 5 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70804/70804_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70804/70804_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2012-01-13 | Lista III | View Edit Delete | |||||||||||
| 662922 | 70804 | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. , 10 parches | 35 microgramos/h | 74 | 10 | 28 | 10 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70804/70804_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70804/70804_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2015-11-11 | Lista III | View Edit Delete | |||||||||||
| 662935 | 70805 | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. , 5 parches | 52,5 microgramos/h | 74 | 5 | 28 | 5 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70805/70805_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70805/70805_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-12 | 1 | 1 | 1 | 2009-05-12 | 2009-05-12 | 0 | 2012-01-13 | Lista III | View Edit Delete | |||||||||||
| 662937 | 70805 | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. , 10 parches | 52,5 microgramos/h | 74 | 10 | 28 | 10 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70805/70805_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70805/70805_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-12 | 1 | 1 | 1 | 2009-05-12 | 2009-05-12 | 0 | 2015-11-11 | Lista III | View Edit Delete | |||||||||||
| 662948 | 70806 | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. , 5 parches | 70 microgramos/h | 74 | 5 | 28 | 5 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70806/70806_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70806/70806_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2012-01-13 | Lista III | View Edit Delete | |||||||||||
| 662950 | 70806 | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. , 10 parches | 70 microgramos/h | 74 | 10 | 28 | 10 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70806/70806_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70806/70806_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2015-11-11 | Lista III | View Edit Delete | |||||||||||
| 669572 | 63574 | SERACTIL 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERACTIL 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 400 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63574/63574_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63574/63574_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2001-01-11 | 1 | 1 | 1 | 2001-01-11 | 2001-01-11 | 0 | 2011-10-10 | View Edit Delete | ||||||||||||
| 665939 | 10637001 | LEFLUNOMIDA MEDAC 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEFLUNOMIDA MEDAC 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10637001/10637001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10637001/10637001_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11137 | LABORATORIOS GEBRO PHARMA S.A. | 2011-02-15 | 1 | 1 | 1 | 2011-02-15 | 2011-02-15 | 1 | 2011-07-27 | View Edit Delete | ||||||||||||
| 665941 | 10637006 | LEFLUNOMIDA MEDAC 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEFLUNOMIDA MEDAC 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 20 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10637006/10637006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10637006/10637006_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11137 | LABORATORIOS GEBRO PHARMA S.A. | 2011-02-15 | 1 | 1 | 1 | 2011-02-15 | 2011-02-15 | 1 | 2011-07-27 | View Edit Delete | ||||||||||||
| 673208 | 71107 | METOJECT 7,5 mg/ 0,15 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | METOJECT 7,5 mg/ 0,15 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,15 ml | 7,5 mg inyectable 0,15 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71107/71107_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71107/71107_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11137 | LABORATORIOS GEBRO PHARMA S.A. | 2009-06-30 | 1 | 1 | 1 | 2009-06-30 | 2011-08-08 | 1 | 2011-09-14 | 663183, 673021 | View Edit Delete | |||||||||||
| 673209 | 71108 | METOJECT 10 mg/ 0,20 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | METOJECT 10 mg/ 0,20 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,2 ml | 10 mg inyectable 0,2 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71108/71108_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71108/71108_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11137 | LABORATORIOS GEBRO PHARMA S.A. | 2009-06-30 | 1 | 1 | 1 | 2009-06-30 | 2011-08-08 | 1 | 2011-09-14 | 663184, 673022 | View Edit Delete |
Page 7 of 1036, showing 20 records out of 20704 total, starting on record 121, ending on 140